Induction and Standard Immunosuppression

Newland, David M.; Nemeth, Thomas L.

doi:10.1007/978-3-319-07284-5_45

Cited by 1 publication

(1 citation statement)

References 112 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This protocol results in one-year graft survival in 90% of cases and avoids episodes of acute organ rejection in 80% of cases. Alternative treatment regimens allow the use of an mTOR inhibitor, including rapamycin, as an alternative to CNI or MMF [3][4][5][6][7].…”

Section: Introductionmentioning

confidence: 99%

The Effects of Chronic Immunosuppressive Treatment on Morphological Changes in Cardiac Tissue and the Balance between Matrix Metalloproteinases (MMP-2 and MMP-9) and Their Inhibitors in the Rat Heart

Surówka,

Żołnierczuk,

Prowans

et al. 2024

IJMS

View full text Add to dashboard Cite

Using different three-drug immunosuppressive treatment regimens in a rat model, we aimed to determine the effects of long-term therapy on metalloproteinase-2 and metalloproteinase-9 activity and the expression of their inhibitors, as well as to assess the morphology of the animals’ cardiac tissue. Our results suggest that chronic use of immunosuppressive drugs disrupts the balance between the activity of MMPs and TIMPs. Depending on the type of drug regimen used, this leads to abnormalities in the cardiac structure, collagen fiber accumulation, or cardiomyocyte hypertrophy. The information obtained in the present study allows us to conclude that the chronic treatment of rats with the most common clinical immunosuppressive regimens may contribute to abnormalities in the myocardial structure and function. The results presented in this study may serve as a prelude to more in-depth analyses and additional research into the optimal selection of an immunosuppressive treatment with the lowest possible risk of cardiovascular complications for patients receiving organ transplants.

show abstract